Italy· 049544012
PONVORY*14 cpr rivestite confezione di inizio trattamento
A ponesimod product containing ponesimod, registered in Italy by LAB.JUVISE' PHARMACEUTICALS, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Ponesimod is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AE04 (ponesimod), each read from that country’s own register.
- This record: Italy
- 7 of them publish a price we can compare per daily dose
Ponesimod · ATC L04AE04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ponesimod costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- Italy: $69.77 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Ponesimod · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- IT Italy$69.77
- CH Switzerland$69.06
The record
At a glance
- Active substance
- Ponesimod
- Manufacturer
- LAB.JUVISE' PHARMACEUTICALS
- Country
- Italy (IT)
- ATC code
- L04AE04
- ATC class
- Ponesimod
- Defined daily dose
- 20 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic049544012PONVORY*14 cpr rivestite confezione di inizio trattamentoEUR 1715.89
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ponesimod in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPonvory 10mg tabletsJuvise Pharmaceuticals
- NorwayPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- SwitzerlandPonvory 10 mg, FilmtablettenMedius AG
- CzechiaPONVORYLaboratoires Juvisé Pharmaceuticals, Villeurbanne
- IrelandPonvory 2 mg+3 mg+4 mg+5 mg+6 mg+7 mg+8 mg+9 mg+10 mg film-coated tabletsLaboratoires Juvise Pharmaceuticals
- IcelandPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- United StatesPONVORYJanssen Pharmaceuticals, Inc
- SpainPONVORY 2, 3, 4, 5, 6, 7, 8, 9 y 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULALaboratoires Juvise Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ponvory
- Liechtenstein · Ponvory
- Norway · Ponvory
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e54b5c09-9296-45cc-b020-c1033f1d28c5 GET /v1/drugs/e54b5c09-9296-45cc-b020-c1033f1d28c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 1715.89,
"source": "aifa",
"currency": "EUR",
"strength": "PONESIMOD 14 UNITA' USO ORALE",
"substance": "Ponesimod",
"equivalence_group": "LXX",
"transparency_flag": null
}See everything about ponesimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.